"Stabilized Norovirus Virus-Like Particles As Vaccine Immunogens" in Patent Application Approval Process (USPTO 20230381293).

A patent application has been filed for a vaccine that targets norovirus, a highly contagious virus that causes gastroenteritis. The vaccine is composed of modified norovirus virus-like particles (VLPs) that have been designed to be more stable. These VLPs can induce an immune response and potentially treat norovirus infections. The patent application also describes methods for producing the VLPs, identifying antibodies that bind to them, and identifying samples with a neutralizing antibody response to norovirus. [Extracted from the article]